Correlation Between Recursion Pharmaceuticals and VectivBio Holding

Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and VectivBio Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and VectivBio Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Recursion Pharmaceuticals and VectivBio Holding AG, you can compare the effects of market volatilities on Recursion Pharmaceuticals and VectivBio Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of VectivBio Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and VectivBio Holding.

Diversification Opportunities for Recursion Pharmaceuticals and VectivBio Holding

0.0

Correlation Coefficient

Recursion Pharmaceuticals  VectivBio Holding

Pay attention - limited upside

The 3 months correlation between Recursion and VectivBio is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and VectivBio Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VectivBio Holding and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with VectivBio Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VectivBio Holding has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and VectivBio Holding go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and VectivBio Holding

If you would invest  439.00  in Recursion Pharmaceuticals on May 28, 2025 and sell it today you would earn a total of  44.00  from holding Recursion Pharmaceuticals or generate 10.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Recursion Pharmaceuticals  vs.  VectivBio Holding AG

Recursion Pharmaceuticals

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

VectivBio Holding

Risk-Adjusted Performance

Weakest

Over the last 90 days VectivBio Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, VectivBio Holding is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Recursion Pharmaceuticals and VectivBio Holding

The main advantage of trading using opposite Recursion Pharmaceuticals and VectivBio Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, VectivBio Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VectivBio Holding will offset losses from the drop in VectivBio Holding's long position.

The idea behind Recursion Pharmaceuticals and VectivBio Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.